Found: 88 articles

Article Edition
A.S. Ametov (1), E.A. Tertychnaya (2)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
№14 / 2019
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
№4 / 2019
T.N. Markova (1, 2)
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
№4 / 2019
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
№4 / 2019
L.A. Sharonova, A.F. Verbovoy
The place of glyflozins in the management of type 2 diabetes mellitus
№4 / 2019
A.P. Pereverzev, O.D. Ostroumova, O.N. Tkacheva
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
№4 / 2019
K.V. Antonova (1), M.M. Tanashyan (1), M.Yu. Maksimova (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
№4 / 2019
G.I. Izhbuldina (1), L.B. Novikova (2)
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
№4 / 2019
M.B. Antsiferov (1), B.B. Kvasnikov (2)
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
№4 / 2019
I.G. Tsvetkova (1), A.N. Kaukova (2), N.A. Belyakova (1), O.A. Vasyutkova (2), O.V. Konovalova (2), A.V. Lareva (1)
DISTURBANCES OF THE AUTONOMIC INNERVATION OF THE CARDIOVASCULAR SYSTEM AND HEMOSTASIS: THEIR ROLE IN THE CHANGE OF MICROCIRCULATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
№16 / 2017
O.S. Elsukova, A.A. Sobolev
ADVANTAGES OF SWITCH TO PREMIXED INSULIN DEGLUDEC/ ASPART IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED AN OPTIMAL CONTROL WITH PREVIOUS INSULIN THERAPY
№16 / 2017
M.B. Antsiferov
THE USE OF INSULIN GLARGINE 300 IU/ML (TOUJEO SOLOSTAR®) IN REAL CLINICAL PRACTICE
№16 / 2017


Бионика Медиа